Uridine diphosphate N-acetylglucosamine

From WikiMD's WELLNESSPEDIA

(Redirected from UDP-N-acetylglucosamine)

Structure of UDP-N-acetylglucosamine

Uridine diphosphate N-acetylglucosamine (UDP-GlcNAc) is a nucleotide sugar that plays a crucial role in the metabolism of carbohydrates. It is a key substrate for the synthesis of glycoproteins and glycolipids.

Structure[edit]

UDP-GlcNAc is composed of the nucleotide uridine diphosphate (UDP) linked to N-acetylglucosamine (GlcNAc), a derivative of glucosamine. The structure of UDP-GlcNAc includes a uracil base, a ribose sugar, and a diphosphate group, which is connected to the N-acetylglucosamine moiety.

Biosynthesis[edit]

The biosynthesis of UDP-GlcNAc occurs in the cytosol of cells. It begins with the conversion of fructose-6-phosphate to glucosamine-6-phosphate by the enzyme glutamine--fructose-6-phosphate aminotransferase. This is followed by acetylation to form N-acetylglucosamine-6-phosphate, which is then converted to N-acetylglucosamine-1-phosphate. Finally, the enzyme UDP-N-acetylglucosamine pyrophosphorylase catalyzes the formation of UDP-GlcNAc from N-acetylglucosamine-1-phosphate and UTP.

Function[edit]

UDP-GlcNAc serves as a donor of N-acetylglucosamine in the synthesis of glycoproteins and glycolipids. It is involved in the O-GlcNAcylation of proteins, a post-translational modification that regulates various cellular processes. UDP-GlcNAc is also a precursor in the biosynthesis of hyaluronic acid, heparan sulfate, and chondroitin sulfate.

Clinical significance[edit]

Alterations in UDP-GlcNAc metabolism have been linked to several diseases, including diabetes mellitus, cancer, and congenital disorders of glycosylation. The regulation of UDP-GlcNAc levels is critical for maintaining normal cellular function and homeostasis.

Related pages[edit]

References[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.